Y. Mitsuda

发表

Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen

Y. Nishiyama, R. Massey, S. Gorantla, 2014, AIDS.

Toward Selective Covalent Inactivation of Pathogenic Antibodies

Y. Nishiyama, S. Paul, S. Planque, 2004, Journal of Biological Chemistry.

Antibodies to a Superantigenic Glycoprotein 120 Epitope as the Basis for Developing an HIV Vaccine

Y. Nishiyama, R. Massey, M. Morris, 2012, The Journal of Immunology.

HIV Vaccine 120 Epitope as the Basis for Developing an Antibodies to a Superantigenic Glycoprotein

Y. Nishiyama, R. Massey, C. Hanson, 2012 .

Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies

R. Kyle, Y. Nishiyama, S. Paul, 2007, Molecular biotechnology.

Catalytic antibody light chain capable of cleaving a chemokine receptor CCR‐5 peptide with a high reaction rate constant

N. Yamamoto, Y. Mitsuda, Kumi Tsuruhata, 2004, Biotechnology and bioengineering.

Catalytic features of monoclonal antibody i41SL1‐2 subunits

Y. Mitsuda, T. Uda, E. Hifumi, 2003, Biotechnology and bioengineering.

Endopeptidase character of monoclonal antibody i41-7 subunits.

Y. Mitsuda, T. Uda, E. Hifumi, 2003, Immunology letters.

Physiological IgM Class Catalytic Antibodies Selective for Transthyretin Amyloid*

Kenji Watanabe, E. Brown, Y. Nishiyama, 2014, The Journal of Biological Chemistry.